APi Group heads into its Q1 2026 earnings call on May 15 with two of its most senior figures having sold tens of millions in stock this week — a strikingly visible signal ahead of the company's biggest near-term catalyst.
Co-Chairman James Lillie and Director Ian Ashken collectively unloaded more than $46 million in shares across May 4–5, with Ashken's single largest transaction alone coming to $38 million at $44.71. These weren't small planned-sale filings. The cluster of trades, executed at prices between $44.71 and $45.86, lands while the stock has already pulled back 5.3% on the week to $43.16 — meaning both insiders sold above where the market currently prices shares. The net insider position for the 90-day window remains solidly positive at over $214 million in net inflows (reflecting earlier grant-and-exercise patterns), but the directional read this week is unmistakably one-sided: those closest to the business chose to reduce ahead of Thursday's print.
The selling coincided with the company's decision to price $500 million in senior notes at 5.75%, due 2034, to fund fire protection acquisitions — a capital raise that simultaneously signals growth confidence and adds leverage. The bond offering closed May 8, the same week as the insider sales, compressing sentiment on the stock. Short interest has climbed alongside the uncertainty. SI % of Free Float has risen to 2.1%, up from roughly 1.7% a month ago and the highest level since mid-April. That 25% month-on-month increase in shares short is notable directionally, though at 2.1% of float the absolute level remains modest — this is bears testing the waters, not a crowded short. Borrow cost has drifted higher to 0.49% and is up about 44% over the past month, but remains well within easy-borrow territory. Availability is wide; there is no squeeze setup here.
Options traders are not especially defensive. The put/call ratio at 0.25 is fractionally below its 20-day average of 0.26 — a z-score of just -0.23 — which is about as neutral as it gets. The 52-week PCR range runs from 0.03 to 0.81, so the current reading sits well inside historical norms. The market is not positioning aggressively for a downside move, even with the insider selling fresh in the tape.
The Street, for its part, leaned bullish immediately after the last earnings print on April 30, when the stock fell 5.6% on the day. Barclays raised its target to $54 on May 7. UBS lifted to $56 and Citigroup to $53 on May 1, both maintaining Buy ratings. The consensus target of $53.20 implies roughly 23% upside from current levels — a gap that has opened up precisely because the stock has given back ground this month. No firm has cut its rating or pulled a Buy in the recent cluster. The EV/EBITDA multiple has eased to 16.9x, down about 0.7x over 30 days, and the PE sits at 24.2x — both multiples drifting lower with the price, which the Street appears to view as a buying opportunity rather than a structural concern. Among peers, WSC surged 18% on the week while FIX added 2.5% — a reminder that construction and engineering names can move sharply on earnings surprises, in either direction. DY fell 6%, roughly in line with APG, suggesting the sector itself is mixed rather than uniformly under pressure.
APG's own recent earnings history offers limited comfort for bulls going into Thursday. The April 30 print produced a 5.6% single-day drop and an 8.3% loss over the following five sessions. With the bond offering adding a new leverage question, insider selling providing a notable optic, and the stock already down on the month, the May 15 call is a moment where management's tone on free cash flow conversion and acquisition integration will matter as much as the headline numbers themselves.
See the live data behind this article on ORTEX.
Open APG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
